Abstract
Metabolic syndrome (MS) is a pathological condition with a high potential to predispose an individual to cardiovascular diseases and type 2 diabetes mellitus, highlighting the importance of studies examining potential treatments for MS. Among these, the use of beta-alanine stands out as a promising supplement capable of mitigating the physiological damage caused by MS. Some research emplo…